Tenure-track faculty position now open! Read below to learn how to join the interdisciplinary BIBC Team.

Welcome to the University of Michigan and the BioInnovations in Brain Cancer!

The BioInnovations in Brain Cancer Initiative (BIBC) at the University of Michigan invites applications for a tenure-track position at any level in any areas pertaining to translational or basic brain cancer biology research and/or development of cutting-edge technological approaches for treatment. Interests include brain cancer biology and technology research, i.e., drug/molecular transport/imaging in the brain tissue, cellular and exosome mediated therapies, detection of cancer cells and biomarkers, translation-focused glioma, immune therapies, epigenetics and/or 3D single cell transcriptomics, blood-brain disruption, and drug/gene delivery.

Applications will be accepted on a rolling basis, but review of applications will begin on November 1st, 2023.

Position Overview

The University of Michigan – widely regarded as one of the nation’s finest research institutions – is an energetic and diverse community of students, scholars, researchers, scientists and artists. Each year, more than 35,000 people from all 50 states and more than 100 countries are drawn to the University by its reputation for research and scholastic innovation and excellence, academic accomplishment and artistic freedom.

The University of Michigan BioInnovation in Brain Cancer seeks to:

  • Promote and develop cross-disciplinary collaborations at the interface of drug technology and brain cancer research on campus.
  • Mentor the next diverse generation of scientists in an equitable and inclusive way.
  • Enrich the U-M’s intellectual and training environment around drug discovery, technology and delivery targeted towards novel brain tumor diagnostics and therapeutics.
  • Leverage and coalesce the strengths of the U-M technologists, clinicians, and brain cancer biology researchers, ranging from novel drug delivery methods, enhanced tissue imaging, gene/immunotherapy, controlled drug release, cancer antigen and mutation detection, nanotechnology, and much more.
  • Provide a central organizational structure through the Biointerfaces Institute to provide common resources, including core instrumentation and helping support collaborative research grants.

We welcome your application and assure you that it will be given the utmost attention by the search committee members. The University of Michigan is supportive of the needs of dual career couples and is a non-discriminatory, affirmative action employer. The search committee may correspond with you directly after its initial review of all applicant files.

We wish you continued success in your scientific career, and thank you again for submitting an application for a faculty position in our Initiative and at the University of Michigan.


Maria G. Castro, Ph.D., Co-Director, BioInnovations in Brain Cancer, R. C. Schneider Collegiate Professor of Neurosurgery, Professor, Cell and Developmental Biology, Director, NIH Cancer Biology Training Grant, Steering Committee Member, Woman of Color in the Academy Project (WOCAP)

Steven P. Schwendeman, Ph.D., Co-Director, BioInnovations in Brain Cancer, Chair and Ara G. Paul Professor of Pharmaceutical Sciences, College of Pharmacy, and Professor of Biomedical Engineering, College of Engineering

Please direct any questions to bibc.program@umich.edu